2-Benzyloxy-4-benzaldehyde β-D-Glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate
- $140 - $1100
- Product name: 2-Benzyloxy-4-benzaldehyde β-D-Glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate
- CAS: 62346-08-1
- MF: C27H28O12
- MW: 544.5
- EINECS:
- MDL Number:
- Synonyms:2-Benzyloxy-4-benzaldehyde β-D-Glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate;β-D-Glucopyranosiduronic acid, 4-formyl-2-(phenylmethoxy)phenyl, methyl ester, triacetate (9CI)
3 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 25mg
- 250mg
- ManufacturerMedical Isotopes, Inc.
- Product number43678
- Product description2-Benzyloxy-4-benzaldehydeβ-D-GlucopyranosiduronicAcidMethylEster2,3,4-Triacetate
- Packaging25mg
- Price$625
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB276395
- Product description2-Benzyloxy-4-benzaldehydeβ-D-GlucopyranosiduronicAcidMethylEster2,3,4-Triacetate
- Packaging25mg
- Price$140
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB276395
- Product description2-Benzyloxy-4-benzaldehydeβ-D-GlucopyranosiduronicAcidMethylEster2,3,4-Triacetate
- Packaging250mg
- Price$1100
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 43678 | 2-Benzyloxy-4-benzaldehydeβ-D-GlucopyranosiduronicAcidMethylEster2,3,4-Triacetate | 25mg | $625 | 2021-12-16 | Buy |
TRC | B276395 | 2-Benzyloxy-4-benzaldehydeβ-D-GlucopyranosiduronicAcidMethylEster2,3,4-Triacetate | 25mg | $140 | 2021-12-16 | Buy |
TRC | B276395 | 2-Benzyloxy-4-benzaldehydeβ-D-GlucopyranosiduronicAcidMethylEster2,3,4-Triacetate | 250mg | $1100 | 2021-12-16 | Buy |
Properties
storage temp. :Refrigerator
solubility :Chloroform, Dichloromethane, Ethyl Acetate
form :Solid
color :Off-white
solubility :Chloroform, Dichloromethane, Ethyl Acetate
form :Solid
color :Off-white
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|